AAA November 2012 – Page 20

Trivitron distributes to Fidelity

Fidelity Growth Partners India (FGPI), a regional corporate venturing unit of US-based mutual fund manager Fidelity, has invested R400 crores ($75m) to partly buy out minority shareholders in Trivitron Healthcare. This investment provides partial exits for ePlanet Ventures and Headland Capital, which have been invested in Trivitron since 2007. Trivitron is an India-based wholesale distributor… Continue reading Trivitron distributes to Fidelity

GE outsources to Syngene

GE Capital, the financial services division of US-listed industrial conglomerate General Electric, has agreed to pay R125 crore ($23m) for a 7.69% stake in Syngene International, a research subsidiary of India-based biotechnology company Biocon. Biocon had been preparing to float Syngene, which has annual sales of R400 crore last year, but will make an initial… Continue reading GE outsources to Syngene

Ipsen prepares for Inspiration write-off

Inspiration Biopharmaceuticals, a US-based company developing a treatment for blood disorders backed by France-based biotech firm Ipsen, has filed for chapter 11 bankruptcy and is about to hire an investment bank to manage a sale process. Ipsen said it had provided $18.3m in debtor-in-possession financing to help manage disposition of Inspiration’s assets and faces a… Continue reading Ipsen prepares for Inspiration write-off